Nucleus
metrics 2024
Empowering researchers through open access to cutting-edge discoveries.
Introduction
Nucleus is a distinguished academic journal published by Taylor & Francis Inc, dedicated to advancing the fields of Cell Biology and Medicine. Since its inception, the journal has gained significant recognition, achieving a Q1 ranking in both Cell Biology and Medicine (miscellaneous) categories in 2023. With a focus on innovative research that intersects molecular biology and genetics, Nucleus serves as a vital platform for researchers and professionals aiming to disseminate findings that contribute to our understanding of cellular mechanisms and their implications in health and disease. The journal's commitment to Open Access since 2018 ensures that cutting-edge research is readily available to the global community, fostering collaboration and engagement across disciplines. Located in Philadelphia, PA, Nucleus not only aims to publish high-quality articles but also aspires to influence future research directions in the biological sciences, making it an essential resource for anyone involved in the life sciences.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
NUCLEIC ACIDS RESEARCH
Advancing Knowledge in Nucleic Acid ScienceNUCLEIC ACIDS RESEARCH, published by Oxford University Press, is a premier peer-reviewed journal in the field of genetics, holding a prestigious Q1 ranking in this domain as of 2023. Since its inception in 1974 and with a converged publication horizon extending to 2024, this journal has established itself as a vital resource for researchers and professionals interested in the molecular aspects of nucleic acids, encompassing DNA and RNA studies as well as their implications in biochemistry and molecular biology. With an impressive Scopus rank of #6 out of 347 in Genetics, this journal is positioned in the 98th percentile among its peers, highlighting its significant impact and relevance in the scientific community. As an open access journal since 2005, NUCLEIC ACIDS RESEARCH ensures wide dissemination of knowledge, promoting collaborative advancements in genetic research. For those looking to stay at the forefront of nucleic acid research, this journal remains an essential publication for accessing cutting-edge findings and innovative methodologies in the field.
NUCLEAR TECHNOLOGY
Connecting Scholars in the Nuclear Technology SphereNUCLEAR TECHNOLOGY is a leading academic journal published by TAYLOR & FRANCIS INC, dedicated to the expansive field of nuclear science and engineering. With a robust ISSN of 0029-5450 and an E-ISSN of 1943-7471, this journal provides invaluable insights and cutting-edge research from 1971 to 2024. Positioned in the esteemed Q2 category for Condensed Matter Physics, Nuclear and High Energy Physics, and Nuclear Energy and Engineering, it boasts respectable Scopus rankings, underscoring its impact and relevance within the academic community. NUCLEAR TECHNOLOGY serves as a crucial platform for researchers, professionals, and students, fostering an exchange of knowledge that advances the understanding and application of nuclear technologies. While it operates on a subscription model, this journal remains a vital resource for those aiming to contribute to or stay at the forefront of developments in nuclear technology.
RNA
Connecting Discoveries in RNA BiologyRNA is a premier journal in the field of molecular biology, published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT. With an impressive impact factor reflected by its Q1 status in the Molecular Biology category, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the role of RNA in biological processes. Spanning over two decades of impactful research from 1995 to 2024, RNA covers a broad spectrum of topics, including RNA biology, gene regulation, and therapeutic innovations. Researchers can access its extensive array of original research articles, reviews, and commentary, making it a vital conduit for new discoveries and methodologies in the field. With its high ranking within Scopus at Rank #115/410 and a 72nd percentile ranking in the domain of Biochemistry, Genetics, and Molecular Biology, RNA continues to advance the understanding of RNA and its critical contributions to life sciences.
Non-coding RNA Research
Bridging Science and Therapeutics through Non-Coding RNANon-coding RNA Research, published by KEAI PUBLISHING LTD, is a leading open-access journal dedicated to advancing the field of non-coding RNA, a critical component in the landscape of molecular biology and genetics. Established in 2016, this journal aims to provide a platform for the dissemination of high-quality research focusing on the roles, mechanisms, and therapeutic potentials of non-coding RNAs in various biological processes and diseases. With impressive Scopus rankings placing it in the top quartile for both Biochemistry and Medical Biochemistry, as well as notable standings in Genetics and Molecular Biology, Non-coding RNA Research continues to attract contributions from globally recognized experts. The journal's commitment to open access ensures broad visibility and engagement with cutting-edge discoveries, thereby fostering an inclusive scientific dialogue that enhances understanding and innovation in this rapidly evolving field. For researchers and scholars, the opportunity to publish in a Q1 ranked journal not only validates their work but also enhances its impact, making Non-coding RNA Research an indispensable resource for anyone interested in the intricate workings of non-coding RNA.
JOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS
Advancing the Frontiers of Nuclear and Particle PhysicsJOURNAL OF PHYSICS G-NUCLEAR AND PARTICLE PHYSICS, published by IOP Publishing Ltd, stands as a premier journal in the realm of Nuclear and High Energy Physics. With an established presence since 1989 and currently converging toward 2024, this influential journal emphasizes groundbreaking research and discoveries in particle physics, fostering the dissemination of knowledge among a global audience of researchers, professionals, and students. Recognized for its high-quality publications, it holds a Q1 ranking in its category for 2023, placing it at an impressive 87th percentile among 87 journals in its field as per Scopus Rankings. The journal's impact is reflected in its esteemed reputation, making it an essential resource for advancing the frontiers of physics. Although it currently does not operate under an open access model, the journal ensures that subscribers receive comprehensive insights into the latest developments and theoretical advances that shape our understanding of the universe.
CURRENT OPINION IN CELL BIOLOGY
Elevating the Discourse in Cell BiologyCURRENT OPINION IN CELL BIOLOGY, published by CURRENT BIOLOGY LTD, serves as a vital resource for scholars and professionals in the dynamic field of cell biology. With a solid Q1 ranking and impressive Scopus ranking of #33 out of 285 in the category of Cell Biology, this journal is recognized for its high impact and relevance among its peers, boasting an excellent percentile ranking of 88th. Established in 1989, it provides insightful reviews and perspectives that capture the latest developments and emergent trends in cellular research, making it indispensable for those aiming to deepen their understanding of cellular mechanisms and innovations. While the journal does not offer open access, its carefully curated content ensures that subscribers receive top-tier scholarly discourse. Situated in the heart of the United Kingdom, CURRENT OPINION IN CELL BIOLOGY continues to shape the conversation in a field that is critical to advancements in biochemistry, genetics, and molecular biology.
GENES & DEVELOPMENT
Unraveling the Mysteries of Genes and DevelopmentGENES & DEVELOPMENT, published by COLD SPRING HARBOR LAB PRESS, stands as a premier journal in the fields of Developmental Biology and Genetics, boasting a remarkable impact factor that reflects its prestigious position in the academic community—ranking Q1 in both disciplines as of 2023. Since its inception in 1987, this journal has been at the forefront of disseminating cutting-edge research, effectively bridging the gap between laboratory breakthroughs and their applications in health and disease. Researchers and professionals rely on GENES & DEVELOPMENT for its rigorous peer-review process and its commitment to promoting innovative studies that unravel the complexities of gene functions and developmental processes. With Scopus rankings placing it in the top percentile among its peers, this journal serves as a vital resource for students and established scientists alike, aspiring to expand their knowledge and contribute to the ever-evolving landscape of genetic and developmental research.
NUCLEAR PHYSICS A
Unveiling the Mysteries of Nuclear InteractionsNUCLEAR PHYSICS A, published by Elsevier, is a leading international journal dedicated to the fields of Nuclear and High Energy Physics. With an ISSN of 0375-9474 and E-ISSN 1873-1554, the journal has been pivotal in advancing research since its inception in 1967 and is set to continue influencing the discipline through 2025. It holds a commendable Q2 classification in the 2023 category of Nuclear and High Energy Physics, ranking 32nd out of 87 journals in its field according to Scopus, placing it in the 63rd percentile. NUCLEAR PHYSICS A provides valuable insights and disseminates cutting-edge research, aiding researchers, professionals, and students in their academic and practical pursuits. Though it does not currently offer open access, the journal remains a vital resource for those engaged in the exploration of nuclear phenomena and theoretical advancements in high-energy physics.
EUROPEAN PHYSICAL JOURNAL A
Catalyzing Advances in High Energy Physics ResearchEUROPEAN PHYSICAL JOURNAL A (EPJ A), published by Springer, is a premier journal in the field of Nuclear and High Energy Physics, dedicated to fostering innovative research and scholarly communication within the scientific community. With an impressive impact factor that reflects its significant contribution to the discipline, EPJ A ranks in the Q1 category and boasts a Scopus rank of 24 out of 87, placing it in the 72nd percentile of its field for 2023. This journal, with its ISSN 1434-6001 and E-ISSN 1434-601X, embraces a commitment to open access, ensuring that cutting-edge research is accessible to a global audience. With coverage from 1998 to 2024, EPJ A continues to be a vital resource for researchers, professionals, and students alike, promoting collaboration, knowledge sharing, and advancements in the vast landscape of nuclear physics and high-energy interactions. Located in Germany with a representative address in New York City, this journal serves as a bridge for international scientific discourse.
FEBS LETTERS
Fostering Knowledge Exchange in Life SciencesFEBS LETTERS, published by Wiley, is a prestigious journal that has firmly established its place in the fields of biochemistry, biophysics, genetics, molecular biology, cell biology, and structural biology. With an esteemed history dating back to 1968, this journal continues to be a vital resource for researchers and professionals involved in the biological sciences. It boasts impressive quartile rankings, including Q1 statuses in several categories such as Biochemistry and Genetics, reflecting its high impact factor and significant contribution to scientific discourse. FEBS LETTERS provides a platform for innovative findings and critical reviews, fostering the exchange of knowledge and ideas within the scientific community. Although it operates under a subscription model, the journal ensures broad dissemination of groundbreaking research through its rigorous peer-review process. The vibrant discussions encouraged by articles published in FEBS LETTERS aim to inspire current and future generations of scientists to push the boundaries of biological understanding, making it an indispensable resource for anyone dedicated to advancing their knowledge in these dynamic fields.